Bevacizumab Versus Triamcinolone Acetonide for the Treatment of Keloids.

Summary

The study compares the efficacy and safety of intralesional bevacizumab versus corticosteroids for the treatment of keloids. Assessment will be done clinically by the use of Modified Vancouver Scar Scale. Erythema index will be measured by spectrophotometry. The levels of Vascular Endothelial Growth Factor, collagen type 1 and collagen type 3 in the lesions before and after each treatment modality.

Timeline

Start

2023-09-01

Primary completion

2024-09-01

Completion

2025-07-01

Publications

• Hilal RF, Osama N, El-Tahlawi S, Elbendary A, Nour ZA, Ragab N. Efficacy of Intralesional Bevacizumab Versus Intralesional Triamcinolone Acetonide Injection in the Treatment of Keloids: A Randomized Clinical Trial. Int J Dermatol. 2026 Jun 28. doi: 10.1111/ijd.70548. Online ahead of print.

Drugs

Indications